Published : Apr-2018
No. of Pages : 131
Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porter's Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix
List of Tables
Table 1: Pharmaceutical Market, Belgium, Sales of Patented Drug Products by Major Therapeutic Class ($m), 2015 21
Table 2: Medical Device Market, Belgium, Revenue by Segment ($m), 2017 41
Table 3: Cardiovascular Devices Market, Belgium, Revenue ($m) and Market Share (%) of Major Companies, 2017 42
Table 4: Ophthalmic Devices Market, Belgium, Revenue ($m) and Market Share (%) of Major Companies, 2015 43
Table 5: Orthopedic Devices Market, Belgium, Revenue ($m) and Market Share (%) of Major Companies, 2016 44
Table 6: IVD Market, Belgium, Revenue ($m) and Market Share (%) of Major Companies, 2016 45
Table 7: Hospital Supplies Market, Belgium, Revenue ($m) and Market Share (%) of Major Companies, 2014 46
Table 8: Types of Reimbursement Claims, Belgium, 2017 80
Table 9: Reimbursement Categories, Belgium, 2017 81
Table 10: Co-payments, Belgium, 2017 82
Table 11: Market Authorization Fees, 2018, Belgium 88
Table 12: Patent Fees, Belgium, 2017 98
Table 13: Provisions for the advertisement of medicines for human use, Belgium, 2017 103
Table 14: Pharmacy Licensing Requirements, Belgium, 2017 104
Table 15: Primary Packaging Labeling Information, Belgium, 2017 105
Table 16: Blister Packaging Labeling Information, Belgium, 2017 105
Table 16: Small Packaging Labeling Information, Belgium, 2017 105
Table 17: Trade Fairs, Belgium, 2017 117
List of Figures
Figure 1: Pharmaceutical Market, Belgium, Revenue ($bn), 2010-2017 8
Figure 2: Medical Device Market, Belgium, Revenue ($bn), 2010-2017 8
Figure 3: Country Profile, Belgium, 2018 14
Figure 4: Pharmaceutical Market, Belgium, Revenue ($bn), 2010-2017 16
Figure 5: Pharmaceutical Market, Belgium, Revenue Forecast ($bn), 2018-2022 16
Figure 6: Pharmaceutical Exports ($bn), Belgium, 2010-2017 17
Figure 7: Top Export Partners, Belgium, 2016 17
Figure 8: Pharmaceutical Imports ($bn), Belgium, 2010-2017 18
Figure 9: Top Import Partners, Belgium, 2016 18
Figure 10: Pharmaceutical Market, Belgium, Major therapeutic groups based on sales ($m), 2015 21
Figure 11: Pharmaceutical Market, Belgium, Major Players 23
Figure 12: Medical Device Market, Belgium, Revenue ($bn), 2010-2017 40
Figure 13: Medical Device Market, Belgium, Revenue Forecast ($bn), 2018-2022 40
Figure 14: Medical Device Market, Belgium, Revenue by Segment ($m), 2017 41
Figure 15: Cardiovascular Devices Market, Belgium, Revenue ($m), 2010-2017 42
Figure 16: Cardiovascular Devices Market, Belgium, Market Share of Major Players (%), 2015 42
Figure 17: Ophthalmic Devices Market, Belgium, Revenue ($m), 2010-2017 43
Figure 18: Ophthalmic Devices Market, Belgium, Market Share of Major Players (%), 2017 43
Figure 19: Orthopedic Devices Market, Belgium, Revenue ($m), 2010-2017 44
Figure 20: Orthopedic Devices Market, Belgium, Market Share of Major Players (%), 2016 44
Figure 21: IVD Market, Belgium, Revenue ($m), 2010-2017 45
Figure 22: IVD Market, Belgium, Market Share of Major Companies (%), 2017 45
Figure 23: Hospital Supplies Market, Belgium, Revenue ($m), 2010-2017 46
Figure 24: Hospital Supplies Market, Belgium, Market Share of Major Companies (%), 2017 46
Figure 25: Diagnostic Market, Belgium, Revenue ($bn), 2010-2017 47
Figure 26: Diagnostic Market, Belgium, Revenue ($bn), 2018-2022 47
Figure 27: Medical Device Market, Belgium, Revenue ($bn) of Major Companies, 2016 49
Figure 28: Deal Value and Deal Count, Pharmaceutical Market, Belgium, 2017-2018 69
Figure 29: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Belgium, 2017-2018 69
Figure 30:Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Belgium, 2017-2018 69
Figure 31: Top 5 therapy area by deal value, Pharmaceutical Market, Belgium, 2017-2018 70
Figure 32: Top 5 therapy area by deal number, Pharmaceutical Market, Belgium, 2017-2018 70
Figure 33: VF deals by therapy area, Pharmaceutical Market, Belgium, 2017-2018 (By value and by number) 70
Figure 34: M&A deals by therapy area, Pharmaceutical Market, Belgium, 2017-2018 (By value and by number) 70
Figure 35: PE deals by therapy area, Pharmaceutical Market Belgium, 2017-2018 (By value and by number) 70
Figure 36:Medical Device Market Deals (by deal value, $m), Belgium, 2017-2018 71
Figure 37:Medical Device Market Deals (by deal count), Belgium, 2017-2018 71
Figure 38: Medical Device Market Deals Share (by deal count), Belgium, 2017-2018 71
Figure 39: Medical Device Market Deals Share (by deal value), Belgium, 2017-2018 71
Figure 40: Medical Device, Belgium, Top Therapy Area by Deal Value, 2017-2018 72
Figure 41: Medical Devices, Belgium, Top Therapy Area by Deal Number, 2017-2018 72
Figure 42: Medical Devices, Belgium, M&A Deals by Therapy Area, 2017-2018 72
Figure 43: Medical Devices, Belgium, VF Deals by Therapy Area, 2017-2018 72
Figure 44: Medical Devices, Belgium, PE Deals by Therapy Area, 2017-2018 72
Figure 45: NIHDI Organization Structure, Belgium, 2015 77
Figure 46: Reimbursement Process, Belgium, 2017 79
Figure 47: Out-of-Pocket Expenditure (% of total expenditure on health), Belgium, 2010-2017 83
Figure 48: Annual Rate of Change (%), Health Price Index, Belgium, 2010-2017 83
Figure 49: Federal Agency for Medicines and Health Products, Organization Chart, Belgium, 2017 87
Figure 50: Centralized Procedure, Belgium, 2017 89
Figure 51: Decentralized Procedure, Belgium, 2017 90
Figure 52: Mutual Recognition Procedure, Belgium, 2017 91
Figure 53: Conformity Assessment of Class I Medical Devices, EU, 2017 93
Figure 54: Conformity Assessment of Class IIa Medical Devices, EU, 2017 94
Figure 55: Conformity Assessment of Class IIb Medical Devices, EU, 2017 95
Figure 56: Conformity Assessment of Class III Medical Devices, EU, 2017 96
Figure 57: European Patent Approval Process, EU, 2017 99
Figure 58: Unitary Patent Approval Process, EU, 2017 100
Figure 59: Trademark Approval Process, Belgium, 2018 101
Figure 60: Clinical Trial Approval Process, Belgium, 2017 102
Figure 61: Number of Hospitals, Belgium, 2010-2017 108
Figure 62: Diagnostic Equipment (per million population), Belgium,2010-2017 108
Figure 63: Hospital Beds (per 100,000 population), Belgium, 2010-2017 109
Figure 64: Curative Care Hospital Beds (per 100,000 population), Belgium, 2010-2017 109
Figure 65: Psychiatric Hospital Beds (per 100,000 population), Belgium, 2010-2017 109
Figure 66: Life Expectancy, Belgium, 2010-2017 110
Figure 67: Immunization Rate (%), Belgium, 2010-2017 110
Figure 68: PM2.5 (?g per m3), Belgium, 2010-2017 111
Figure 69: CO2 Emissions (million tons), Belgium, 2010-2017 111
Figure 70: Physicians (per 1,000 population), Belgium, 2010-2017 112
Figure 71: Dentists (per 1,000 population), Belgium, 2010-2017 112
Figure 72: Nurses (per 1,000 population), Belgium, 2010-2017 112
Figure 73: Pharmacists (per 1,000 population), Belgium, 2010-2017 112
Figure 74: Major Causes of Mortality (number of deaths), Belgium, 2014 113
Figure 75: Major Causes of Male Mortality (number of deaths), Belgium, 2014 113
Figure 76: Major Causes of Female Mortality (number of deaths), Belgium, 2014 113
Figure 77: Disability-Adjusted Life Years by Major Disease (000), Belgium, 2015 113
Figure 78: Healthcare Expenditure as Percentage of GDP (%), Belgium, 2010-2017 114
Figure 79: Public-Private Share (%), Belgium, 2010-2017 114
Figure 80: Major Components of Healthcare Spending (%), Belgium, 2015 115
Figure 81:Spending in Pharmaceutical and Healthcare R&D ($bn), Belgium, 2010-2015 115
Figure 82: Opportunities and Challenges 119
